N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 14.82 CNY
Market Cap: 23.9B CNY
Have any thoughts about
Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Write Note

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Cash from Investing Activities
-ÂĄ2.5B
CAGR 3-Years
-39%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Investing Activities
ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Investing Activities
ÂĄ7B
CAGR 3-Years
N/A
CAGR 5-Years
66%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Investing Activities
-ÂĄ1.3B
CAGR 3-Years
N/A
CAGR 5-Years
-2%
CAGR 10-Years
-12%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Investing Activities
ÂĄ5.9m
CAGR 3-Years
-88%
CAGR 5-Years
-80%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Investing Activities
-ÂĄ81.9m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-2.5B CNY

Based on the financial report for Jun 30, 2024, Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -2.5B CNY.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-53%

The average annual Cash from Investing Activities growth rates for Nanjing King-friend Biochemical Pharmaceutical Co Ltd have been -39% over the past three years , -53% over the past five years .

Back to Top